Details
Category: Volume 07 Issue 03 March 2019
Hits: 1117

Title: Outcome of a Rare Case of Early Stage Lung Cancer in a Tertiary Care Center

Authors: Dr Joydeep Singh Vasant, Dr Ashok Kumar Chauhan, Dr Paramjit Kaur, Dr Jyoti Pannu, Dr Roshani Vyas

 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.66

Abstract

Introduction

As per GLOBOCAN 2018, lung cancer is the most common cancer in the world at 11.6% and has the highest mortality. In India it is the fourth most common cancer comprising of 5.9% of all the new cases and is responsible for 9.3 % of all cancer related mortality in both sexes.1 As in developing countries most of the patients present in locally advanced stages. The overall 5-year survival rate of lung cancer is dismal with approximately 15 per cent in developed countries and 5 per cent in developing countries.2 In the department of Radiotherapy PGIMS, Rohtak carcinoma lung constituted 8.1 % of all the cancer patients registered of which less than 1 % are early stage.3 Surgery is the standard mode of treatment of patients with stage I and II tumors and for selective patients with stage III tumors. But only 20% of all the patients presenting with lung cancer are suitable for surgery.4Conventional fractionated radiotherapy is recommended, with reported 5-year local control and overall survival rates ranging from 30% to 50% and 10% to 30% respectively in stage I/II Non-Small cell lung carcinoma.5

References

  1. Ferlay J, Soeriomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2018 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France International Agency for Research on Cancer; 2018.
  2. Parkin DM, Bray F. Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cncer J Clin. 2005;55:74-108
  3. B. D. Sharma PGIMS, Rohtak (India). Data for the year 2017. Retrieved in January 2018 from Radiotherapy OPD record section.
  4. Pearson FG. Current status of surgical resection for lung cancer. Chest 1997;106:337.
  5. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Unchanging clinic-epidemiological profile of lung cancer in North India over three decades. Cancer Epidemiol. 2009;10:1033-4
  6. Yamanashi K, Okumura N, Takahashi A, Nakashima T, Matsuoka T. Surgical andsurvival outcomes of lung cancer patients with intratumoral lung abscesses. JCardiothorac Surg. 2017 May 26;12(1):44.
  7. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111(6):1710–1717
  8. Pairolero PC, Williams DE, Bergstralh EJ, et al. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg. 1984;38(4):331–338.
  9. Feld R, Rubinstein LV, Weisenberger TH. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J ClinOncol. 1984;2(12):1352–1358.
  10. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J ThoracOncol. 2007;2(8):706–714.
  11. Scott WJ, Howington J, Feigenberg S, et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition) Chest. 2007;132(3 Suppl):234S–242S.
  12. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.
  13. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615–622. discussion 622-3.
  14. Wang HH, Deng L, Wen QL, et al. Early postoperative radiotherapy is associated with improved outcomesover late postoperative radiotherapy in the management of completely resected(R0) Stage IIIA-N2 non-small cell lung cancer. Oncotarget. 2017 May23;8(38):62998-63013.

Corresponding Author

Dr Joydeep Singh Vasant

3rd year PG student, Department of Radiotherapy, PGIMS, Rohtak, India